WHO top scientist lauds India's capacity to innovate, produce vaccines at Global Bio-India 2021

The three-day Global Bio-India 2021 was inaugurated Monday by Harsh Vardhan, the minister of Science & Technology, and Health & Family Welfare.

Press Trust of India March 03, 2021 11:32:58 IST
WHO top scientist lauds India's capacity to innovate, produce vaccines at Global Bio-India 2021

Soumya Swaminathan. Image Credit: Youtube

India has shown the capacity to be a global-scale manufacturer and also an innovator when it comes to coronavirus vaccines, World Health Organization's Chief Scientist Soumya Swaminathan said Monday. Speaking at the Global Bio-India 2021, she opined that the fight against the coronavirus pandemic is at a very critical junction now as cases have suddenly gone up, particularly in Europe and America. There are many uncertainties now, especially on the different variants of the virus, she noted.

"India has shown the capacity to be a manufacturer at the global scale and also be an innovator when it came to vaccine development. There is a huge amount of scope to study the impact of vaccines, which needs to be thought-through by a very coordinated approach," she said.

As many as 30 vaccines are at different stages of development in India. Covaxin, developed indigenously by Bharat Biotech, and Covishield, developed by Oxford-AstraZeneca and being manufactured at Serum Institute of India, are already in use in the country.

The vaccine candidates of Zydus Cadila and Russia's Sputnik V are in phase 3 of the human clinical trials. Sputnik V, which is being manufactured by Reddy's Laboratories in India, has initiated the process for Emergency Use Authorisation (EUA) with the Drugs Controller General of India (DCGI).

India has supplied vaccines to several nations while many others have also placed orders for the same.

Vinod Paul, Member (Health), NITI Aayog lauded the efforts of scientific community and said the speed with which the solutions during the pandemic appeared was phenomenal.

The stories of development of vaccines are amazing examples of how time can be compressed and scientific mobilisation can be initiated. The intent to have a global footprint in the manufacturing sector when it came to COVID-19 vaccine was path-breaking and something to be proud of.

We have realised that we have the potential to deliver in a speedy manner, like we did for vaccine distribution, he said.

The three-day Global Bio-India 2021 was inaugurated Monday by Harsh Vardhan, the minister of Science & Technology, and Health & Family Welfare.

Updated Date:

also read

COVID-19 News: 17 states, UTs to miss phase 3 vaccination launch today; daily cases near 4 lakh
India

COVID-19 News: 17 states, UTs to miss phase 3 vaccination launch today; daily cases near 4 lakh

The Central Government, however, rejected the claims of vaccine shortages while maintaining that state governments have "more than one crore" doses

COVID-19 vaccine: Bharat Biotech commences direct supply of Covaxin to 14 states
India

COVID-19 vaccine: Bharat Biotech commences direct supply of Covaxin to 14 states

The Hyderabad-based firm has started supplying its COVID-19 vaccine to the states based on the allocations received by the central government

Russia approves single-dose 'Sputnik Light' vaccine; COVID-19 jab shows 79.4% efficacy
World

Russia approves single-dose 'Sputnik Light' vaccine; COVID-19 jab shows 79.4% efficacy

The Russian vaccine has been approved for use in over 60 countries, but the European Medicines Agency and the US Food and Drug Administration have not okayed it yet